Consumer Health Services

Integrated Consumer Engagement and Support Solutions

Complete, compliant solutions for today's evolving Consumer Health landscape.

ProPhama's Consumer Health Services

Consumer Health Services provide compliant, end-to-end support across consumer engagement, safety monitoring, and quality processes. Expertise spans diverse product portfolios and global markets, ensuring accurate information delivery, consistent consumer experiences, and alignment with regulatory requirements.

Woman shopping at store with smartphone
Braining storming at a business meeting

Our Approach

An Integrated Consumer Health Model

An integrated Consumer Health model supports engagement across multiple touchpoints, including the management of consumer inquiries, proactive identification of Adverse Events and Product Quality Complaints, and timely documentation and reporting in accordance with regulatory requirements. Engagement, safety monitoring, and quality processes are connected to support a consistent, compliant, and consumer-centric experience while safeguarding critical product and patient information.

Structured support solutions strengthen compliance, operational consistency, and risk management across the Consumer Health Service line. Established procedures and controlled processes support data integrity, audit readiness, and regulatory expectations, while enabling accurate identification, documentation, and reporting of safety and quality information within required timelines.

Consumer Health Capabilities

Consumer Health & Information Delivery
Patient support programs icon

Customized Consumer Health Solutions

Tailored service programs designed to your specific needs across diverse product portfolios. These solutions are strategically configured to meet therapeutic area...

Read More

Customized Consumer Health Solutions

Tailored service programs designed to your specific needs across diverse product portfolios. These solutions are strategically configured to meet therapeutic area requirements and product classifications, such as Over-the-Counter (OTC), Nutritional, Cosmeceutical, and Prescription products. Our dedicated call center operations and Consumer Health teams provide expert support by delivering on-label information sourced from approved FAQs and regulatory resources, ensuring consistent and compliant support for both healthcare professionals and consumer inquiries.

Read Less
Decentralized Clinical Trials icon

Over-the-Counter and Retail Product Services

ProPharma direct-to-consumer Consumer Health Services for OTC products has become your primary connection point with end users, delivering the exceptional...

Read More

Over-the-Counter and Retail Product Services

ProPharma direct-to-consumer Consumer Health Services for OTC products has become your primary connection point with end users, delivering the exceptional service quality that drives brand loyalty and repeat purchases.

Read Less
Entrepreneurial

Community Management Capabilities

Modern Consumer Health Services leverage digital platforms to monitor sponsored content and influence partnerships across a range of digital and social media...

Read More

Community Management Capabilities

Modern Consumer Health Services leverage digital platforms to monitor sponsored content and influence partnerships across a range of digital and social media environments.

  • Standardized medical information responses delivered in alignment with approved product labeling and FAQs.
  • Social media and ecommerce monitoring
  • Trend Analysis Reports
Read Less
Pharmacovigilance

Safety & Quality Oversight

Highly Qualified Experts

Consumer Health Services serve as the critical first point of contact for Adverse Events and Product Quality Complaints reporting. Our trained specialists conduct thorough assessments to capture complete Adverse Event and Product Quality Complaint information. Consumer Health Services manage end-to-end quality complaint processes, from documentation through quality assurance coordination and consumer updates.

Global contact center support icon

Consumer Access & Support Programs

Product Reimbursement, Replacement Programs & Financial Assistance

Consumer Health Services provide specialized reimbursement and replacement support.

  • Facilitation of physical and digital coupon distribution.
  • Financial assistance and Co-Pay programs.
  • Sample retrieval services manage specialized logistics including prepaid shipping, proper packaging, and chain of custody
Around the world icon

Global Delivery & Operational Excellence

Multilingual Services

Support available in 35+ languages to serve diverse consumer populations globally.

Contact a Consumer Health Expert

We are committed to supporting consumer safety and experience through our competitive Consumer Health Services. Whether you require robust monitoring of digital and social channels or a full-service approach including engagement and response management, our team of experts is equipped to ensure timely, accurate, and compliant handling of all consumer interactions.

News & Insights

A Risk-Based Road Map for Implementing AI

June 22, 2026

A Risk-Based Road Map for Implementing AI

Discover a risk-based approach to implementing AI in life sciences, ensuring compliance, transparency, and governance throughout the entire lifecycle.

Five Metrics That Predict CRO Success (and How to Measure Them)

June 15, 2026

Five Metrics That Predict CRO Success (and How to Measure Them)

Discover five key metrics to evaluate CRO success, ensuring timely clinical trials and data integrity while minimizing costs. Learn how to measure them effectively.

FDA Adds Bemotrizinol to OTC Sunscreen Monograph: What the New GRASE Determination Means for Manufacturers

June 10, 2026

FDA Adds Bemotrizinol to OTC Sunscreen Monograph: What the New GRASE Determinati...

Learn how bemotrizinol achieved GRASE status and what FDA's final order adding the ingredient to the OTC sunscreen monograph means for manufacturers and product development.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

June 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Case Study Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

May 20, 2026

Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

News & Insights

A Risk-Based Road Map for Implementing AI

June 22, 2026

A Risk-Based Road Map for Implementing AI

Discover a risk-based approach to implementing AI in life sciences, ensuring compliance, transparency, and governance throughout the entire lifecycle.

Five Metrics That Predict CRO Success (and How to Measure Them)

June 15, 2026

Five Metrics That Predict CRO Success (and How to Measure Them)

Discover five key metrics to evaluate CRO success, ensuring timely clinical trials and data integrity while minimizing costs. Learn how to measure them effectively.

FDA Adds Bemotrizinol to OTC Sunscreen Monograph: What the New GRASE Determination Means for Manufacturers

June 10, 2026

FDA Adds Bemotrizinol to OTC Sunscreen Monograph: What the New GRASE Determinati...

Learn how bemotrizinol achieved GRASE status and what FDA's final order adding the ingredient to the OTC sunscreen monograph means for manufacturers and product development.

Previous Post Arrow Next Post Arrow
ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

June 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Case Study Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

May 20, 2026

Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...

Previous Resource Arrow Next Resource Arrow
Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Previous Webinar Arrow Next Webinar Arrow